These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32472661)

  • 1. Global burden of noncommunicable diseases attributable to high fasting plasma glucose.
    Ye L; Xu J; Zhang T; Lin X; Pan X; Zeng W; Ren Y; Shan P
    J Diabetes; 2020 Nov; 12(11):807-818. PubMed ID: 32472661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of cardiovascular disease attributable to high fasting plasma glucose：Findings from the global burden of disease study 2019.
    Dong XJ; Zhang XQ; Wang BB; Hou FF; Jiao Y
    Diabetes Metab Syndr; 2024 May; 18(5):103025. PubMed ID: 38851022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990-2019: An updated analysis for the Global Burden of Disease Study 2019.
    Liang R; Feng X; Shi D; Yang M; Yu L; Liu W; Zhou M; Wang X; Qiu W; Fan L; Wang B; Chen W
    Diabetes Metab Res Rev; 2022 Nov; 38(8):e3572. PubMed ID: 36001650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global burden of metabolic dysfunction-associated steatotic liver disease attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2021.
    Yang Z; Li A; Jiang Y; Maidaiti X; Wu Y; Jin Y
    Sci Rep; 2024 Sep; 14(1):22232. PubMed ID: 39333707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global disease burden of stroke attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2019: An analysis of the Global Burden of Disease Study.
    Liu Y; Wang W; Huang X; Zhang X; Lin L; Qin JJ; Lei F; Cai J; Cheng B
    J Diabetes; 2022 Aug; 14(8):495-513. PubMed ID: 35924673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global, regional, and national burden of chronic kidney disease attributable to high fasting plasma glucose from 1990 to 2019: a systematic analysis from the global burden of disease study 2019.
    Wei H; Ren J; Li R; Qi X; Yang F; Li Q
    Front Endocrinol (Lausanne); 2024; 15():1379634. PubMed ID: 38601204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global burden of noncommunicable disease attributable to high body mass index in 195 countries and territories, 1990-2017.
    Lin X; Xu Y; Xu J; Pan X; Song X; Shan L; Zhao Y; Shan PF
    Endocrine; 2020 Aug; 69(2):310-320. PubMed ID: 32488838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990-2019.
    Tondro Anamag F; Noori M; Nejadghaderi SA; Sullman MJM; Grieger JA; Kolahi AA; Safiri S
    Cancer Med; 2023 Apr; 12(8):10031-10044. PubMed ID: 36951550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019.
    Wang M; Liu J; Yan L; Wang J; Jin Y; Zheng ZJ
    J Nutr Health Aging; 2024 Jun; 28(6):100261. PubMed ID: 38810511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019.
    Safiri S; Nejadghaderi SA; Karamzad N; Kaufman JS; Carson-Chahhoud K; Bragazzi NL; Sullman MJM; Beyranvand MR; Mansournia MA; Almasi-Hashiani A; Collins GS; Kolahi AA
    Front Endocrinol (Lausanne); 2022; 13():879890. PubMed ID: 35966097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
    Chen Y; Liu J; Zhang Q; Chen H; Chai L; Wang Y; Zhang J; Qiu Y; Shen N; Shi X; Wang Q; Wang J; Li S; Li M
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):747-765. PubMed ID: 38367094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of non-communicable diseases attributable to high temperature in a changing climate from 1990 to 2019: a global analysis.
    Zhang JD; Cheng XF; Min SH; Guo RQ; Wang RN; He YT; Zhang YL; Li B
    BMC Public Health; 2024 Sep; 24(1):2475. PubMed ID: 39261784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of non-communicable diseases from infectious causes in 2017: a modelling study.
    Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G
    Lancet Glob Health; 2020 Dec; 8(12):e1489-e1498. PubMed ID: 33098769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global burden of non-communicable diseases attributable to dietary risks in 1990-2019.
    Qiao J; Lin X; Wu Y; Huang X; Pan X; Xu J; Wu J; Ren Y; Shan PF
    J Hum Nutr Diet; 2022 Feb; 35(1):202-213. PubMed ID: 33834556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global, regional, and national burden of blindness and vision loss attributable to high fasting plasma glucose from 1990 to 2019, and forecasts to 2030: A systematic analysis for the Global Burden of Disease Study 2019.
    Li C; Hua G; Liu S; Yu H; Yang X; Liu L
    Diabetes Metab Res Rev; 2024 May; 40(4):e3802. PubMed ID: 38634501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden and trend of diet-related non-communicable diseases in Australia and comparison with 34 OECD countries, 1990-2015: findings from the Global Burden of Disease Study 2015.
    Melaku YA; Renzaho A; Gill TK; Taylor AW; Dal Grande E; de Courten B; Baye E; Gonzalez-Chica D; Hyppӧnen E; Shi Z; Riley M; Adams R; Kinfu Y
    Eur J Nutr; 2019 Apr; 58(3):1299-1313. PubMed ID: 29516222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer mortality trends attributable to high fasting blood sugar over the period 1990-2019 and projections up to 2040.
    Wei Y; Qin Z; Liao X; Zhou X; Huang H; Lan C; Qin W; Zhu G; Su H; Peng T
    Front Endocrinol (Lausanne); 2024; 15():1302436. PubMed ID: 39036051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global and regional estimates of tuberculosis burden attributed to high fasting plasma glucose from 1990 to 2019: emphasis on earlier glycemic control.
    Bian Q; Zhang Y; Xue C; Lu W; Li W; Pan F; Li Y
    BMC Public Health; 2024 Mar; 24(1):782. PubMed ID: 38481192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global, regional, and national time trends in cancer mortality attributable to high fasting plasma glucose: an age-period cohort analysis.
    Xie J; Liu Z; Ren L; He L; Lu S; Meng X; Zhang X; Su Z; Jing S; Shan T; Wang J; Xia R; Feng W; Li Y; Liu N; Liu Y
    BMC Public Health; 2023 Jul; 23(1):1361. PubMed ID: 37454041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of type 1 and type 2 diabetes and high fasting plasma glucose in Europe, 1990-2019: a comprehensive analysis from the global burden of disease study 2019.
    Liang D; Cai X; Guan Q; Ou Y; Zheng X; Lin X
    Front Endocrinol (Lausanne); 2023; 14():1307432. PubMed ID: 38152139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.